Probiotics in the critically ill patient: A double blind, randomized, placebo-controlled trial

Intensive Care Medicine

Volumn 36, Issue 9, 2010, Pages 1540-1547

  Barraud, Damien ^a   Blard, Claire ^b   Hein, François ^a   Marçon, Olivier ^a   Cravoisy, Aurélie ^a   Nace, Lionel ^a   Alla, François ^a   Bollaert, Pierre Edouard ^a   Gibot, Sébastien ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Digestive Surgery Macon Hospital   (France)

Author keywords

ICU acquired infections; Mechanical ventilation; Probiotics

Indexed keywords

ERGYPHILUS; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CATHETER INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; LACTIC ACID BACTERIUM; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; WEANING;

ADULT; AGED; CRITICAL ILLNESS; CROSS INFECTION; DOUBLE-BLIND METHOD; FEMALE; FRANCE; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; LACTOBACILLUS RHAMNOSUS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROBIOTICS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77955919598     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-1927-0     Document Type: Article

References (20)

1. W Isakow LE Morrow MH Kollef 2007 Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations Chest 132 286 294 10.1378/chest.06-2156 17625089 (Pubitemid 47068233)
2. B McNabb W Isakow 2008 Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions Curr Opin Pulm Med 14 168 175 10.1097/MCP.0b013e3282f76443 18427239 (Pubitemid 351572317)
3. PJ Watkinson VS Barber P Dark JD Young 2007 The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review Clin Nutr 26 182 192 10.1016/j.clnu.2006.07.010 17011083 (Pubitemid 46504825)
4. JM Saavedra 2001 Clinical applications of probiotic agents Am J Clin Nutr 73 1147S 1151S 1:CAS:528:DC%2BD3MXktlWhsL4%3D 11393193
5. DM Lilly RH Stillwell 1965 Probiotics: growth-promoting factors produced by microorganisms Science 147 747 748 10.1126/science.147.3659.747 1:CAS:528:DyaF2MXmtFSgtA%3D%3D 14242024
6. Guidelines for the evaluation of probiotics in food: report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food (2002) London, ON, Canada
7. WA Walker 2002 Mechanisms of action of probiotics Clin Infect Dis 46 Suppl 2 S87 S91
8. II Siempos TK Ntaidou ME Falagas 2010 Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials Crit Care Med 38 954 962 10.1097/CCM. 0b013e3181c8fe4b 20016381
9. T Calandra J Cohen International Sepsis Forum Definition of Infection in the ICU Consensus Conference 2005 The international sepsis forum consensus conference on definitions of infection in the intensive care unit Crit Care Med 33 1538 1548 10.1097/01.CCM.0000168253.91200.83 16003060 (Pubitemid 40980610)
10. K Whelan PA Judd MA Taylor 2003 Defining and reporting diarrhoea during enteral tube feeding: do health professionals agree? J Hum Nutr Diet 16 21 26 10.1046/j.1365-277X.2003.00418.x 1:STN:280:DC%2BD3s%2FntFygug%3D%3D 12581406 (Pubitemid 36367484)
11. MG Besselink HC van Santvoort E Buskens MA Boermeester H van Goor HM Timmerman VB Nieuwenhuijs TL Bollen B van Ramshorst BJ Witteman C Rosman RJ Ploeg MA Brink AF Schaapherder CH Dejong PJ Wahab CJ van Laarhoven E van der Harst CH van Eijck MA Cuesta LM Akkermans HG Gooszen Dutch Acute Pancreatitis Study Group 2008 Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Lancet 371 651 659 10.1016/S0140-6736(08)60207-X 18279948
12. KKG Lan DL DeMets 1983 Discrete sequential boundaries for clinical trials Biometrika 70 659 663 10.2307/2336502
13. RC Bone RA Balk FB Cerra RP Dellinger AM Fein WA Knaus RM Schein WJ Sibbald 1992 Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1644 1655 10.1378/chest.101.6.1644 1:STN:280: DyaK383ovFeiuw%3D%3D 1303622
14. WR McCabe GG Jackson 1962 Gram negative bacteremia: I. Etiology and ecology Arch Intern Med 110 845 847
15. PK Jain CE McNaught AD Anderson J MacFie CJ Mitchell 2004 Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial Clin Nutr 23 467 475 10.1016/j.clnu.2003.12.002 15297081 (Pubitemid 39107024)
16. CE McNaught NP Woodcock AD Anderson J MacFie 2005 A prospective randomised trial of probiotics in critically ill patients Clin Nutr 24 211 219 10.1016/j.clnu.2004.08.008 15784480 (Pubitemid 40392804)
17. K Kotzampassi EJ Giamarellos-Bourboulis A Voudouris P Kazamias E Eleftheriadis 2006 Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial World J Surg 30 1848 1855 10.1007/s00268-005-0653-1 16983476 (Pubitemid 44454998)
18. MG Besselink HC van Santvoort W Renooij MB de Smet MA Boermeester K Fischer HM Timmerman U Ahmed Ali GA Cirkel TL Bollen B van Ramshorst AF Schaapherder BJ Witteman RJ Ploeg H van Goor CJ van Laarhoven AC Tan MA Brink E van der Harst PJ Wahab CH van Eijck CH Dejong KJ van Erpecum LM Akkermans HG Gooszen Dutch Acute Pancreatitis Study Group 2009 Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis Ann Surg 250 712 719 10.1097/SLA.0b013e3181bce5bd 19801929
19. A Spindler-Vesel S Bengmark I Vovk O Cerovic L Kompan 2007 Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients J Parenter Enteral Nutr 31 119 126 10.1177/ 0148607107031002119 1:CAS:528:DC%2BD2sXjs12mtrk%3D
20. C Forestier D Guelon V Cluytens T Guillart J Sirot C De champs 2008 Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients Crit Care 12 R69 10.1186/cc6907 18489775 (Pubitemid 351796668)